Developer docs
API playgroundTry for free, no card

Search company profiles

Excelya

Full company profile

uuid0007pt8

Namestring
Excelya
Legal namestring
EXCELYA GROUP
Websiteurl
excelya.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Excelya is a France-headquartered, global full-service Contract Research Organization (CRO) founded in 2014 that delivers clinical research services to biotech, pharmaceutical, and medical device sponsors. The company operates through three commercial engagement models (Full Service CRO, Functional Service Provider, and Clinical Resourcing) delivered across eight Centers of Excellence (Clinical Operations, Pharmacovigilance & Safety, Data Management, eTMF Management, Statistics & Programming, Medical Affairs, Regulatory Affairs, and Quality Assurance) and six therapeutic areas (Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease & Vaccines, Pain Treatment & CNS, and Late Phase & RWE). Across 25+ countries and 16 offices, Excelya employs 1,000+ professionals and reports having supported more than 550 clinical trials.

The company's technology stack is built on partnerships rather than proprietary infrastructure: eTMF runs on Veeva Vault (formalized through a 2021 Veeva Services Partner relationship), and clinical data management supports three of the top five EDC platforms including Viedoc and Oracle Clinical One. Real-world evidence work is differentiated by OMOP Common Data Model expertise, enabling harmonized vocabulary mapping (SNOMED, RxNorm) and federated analytics across hundreds of millions of patient records. Excelya generated ~€70M in combined revenues in 2020 following a same-day acquisition of three European CROs (Zeincro, The Clinical Company, Koehler eClinical), scaling the workforce from a pre-deal base to 800 employees across 24 European countries.

The business model is professional services revenue billed under multi-year contracts with quote-based pricing tied to project scope and engagement model. Go-to-market is enterprise field sales supported by direct RFP submission and active participation in industry conferences (PSI, PV Europe, OCT Europe, ACDM, UBIQ). Customer evidence is anchored by a 10-year pharmacovigilance partnership with UCB and case studies spanning top-20 global pharma, biopharma, generics, and CAR-T developers. In November 2025, Eurazeo acquired a minority stake via a sponsorless leveraged buyout earmarked for growth, US expansion, AI/automation investment, and a co-founder-led management transition.

Short descriptiontext

Excelya is a France-headquartered, global full-service Contract Research Organization delivering clinical trial services through Full Service, FSP, and Resourcing models to biotech, pharmaceutical, and medical device sponsors across 25+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBoulogne-billancourt, France
HQ citystring
Boulogne-billancourt
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices11 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, contract research organization, pharmacovigilance services, clinical data management, biostatistics programming
Industry5 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Health Services8000
Product category
Contract Research Organization Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Research Services
TypeProfessional Services
Description

Excelya generates revenue through providing comprehensive clinical research organization services including full-service CRO, Functional Service Provider (FSP) arrangements, and clinical resourcing solutions to biotech, pharma, and medical device companies.

excelya.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details3 tiers
1Full Service CRO Model
ModelOtherBilling cadenceMulti-year contract
Notes

Comprehensive end-to-end clinical trial services billed per project/engagement

excelya.com
2Functional Service Provider (FSP)
ModelOtherBilling cadenceMulti-year contract
Notes

Flexible staffing and expertise delivery model with shared responsibility for outcomes

excelya.com
3Clinical Resourcing
ModelOtherBilling cadenceMulti-year contract
Notes

Talent pool access for clinical research operations roles

excelya.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Excelya is a global full-service Contract Research Organization (CRO) that delivers clinical research services to biotech, pharmaceutical, and medical device organizations through three contractable engagement models: Full Service CRO (end-to-end trial management), Functional Service Provider (FSP), and Clinical Resourcing. The offering spans eight Centers of Excellence—Clinical Operations, Pharmacovigilance & Safety, Clinical Data Management, Statistics & Programming, Medical Affairs & Medical Writing, eTMF Management, Regulatory Affairs, and Quality Assurance—delivered across six therapeutic specializations including Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease, Pain Treatment & CNS, and Late Phase & Real-World Evidence.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 16% cost reduction achieved for clients
+4 more records
Product overview1 text field

Excelya is a global full-service Contract Research Organization (CRO) offering clinical research services through three engagement models: Full Service CRO (end-to-end trial management), Functional Service Provider (FSP), and Clinical Resourcing. The company operates through eight Centers of Excellence (Clinical Operations, Pharmacovigilance & Safety, Clinical Data Management, Statistics & Programming, Medical Affairs & Medical Writing, eTMF Management, Regulatory Affairs, and Quality Assurance) and covers six therapeutic areas (Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease, Pain Treatment & CNS, and Late Phase & RWE). Excelya delivers services across 25+ countries with 1000+ experts and 16 offices, supporting Biotech, Pharma, and Medical Device organizations from early-phase through post-marketing studies.

Product and service11 records
1Full Service CRO
CategoryClinical Research Services / CRO Engagement Model
2Functional Service Provider (FSP)
CategoryClinical Research Services / CRO Engagement Model
3Clinical Resourcing
CategoryClinical Research Services / CRO Engagement Model
4Clinical Operations
CategoryCenter of Excellence / Clinical Trial Services
5Pharmacovigilance & Safety
CategoryCenter of Excellence / Pharmacovigilance Services
6Clinical Data Management
CategoryCenter of Excellence / Clinical Data Services
7Statistics & Programming
CategoryCenter of Excellence / Biostatistics Services
8Medical Affairs & Medical Writing
CategoryCenter of Excellence / Medical Affairs Services
9eTMF Management
CategoryCenter of Excellence / Trial Document Management
10Regulatory Affairs
CategoryCenter of Excellence / Regulatory Services
11Quality Assurance
CategoryCenter of Excellence / Quality Services
Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-09-01
Description

Partnership with Veeva Systems as primary eTMF provider, enabling Excelya to offer best-in-class electronic Trial Master File management services to clients using market-leading software combined with professional expertise.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-07-06
Description

Zeincro, a CRO primarily operating in Central-Eastern & Southern Europe with expertise in clinical operations, safety and medical affairs, joined Excelya Group. The acquisition expanded Excelya's European footprint to 24 countries.

3The Clinical Company
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-07-06
Description

The Clinical Company, a full-service CRO present in Belgian and Dutch markets specializing in clinical operations, joined Excelya Group to expand services in Benelux region.

excelya.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-07-06
Description

Koehler eClinical, a German specialty CRO with focus on biostatistics and data solutions including proprietary software VITESSA, joined Excelya Group to strengthen data-centric capabilities.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2015-01-01
Description

10-year pharmacovigilance partnership between Excelya and UCB, evolved from operational service delivery to a mature 'one team' model. Excelya provides 24 PV professionals supporting UCB locally across Europe with monthly operational meetings and proactive communication.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1KCR
TypeEmerging player
Description

European-based CRO with overlapping therapeutic areas (oncology, rare disease) and similar mid-size positioning; competes with Excelya for European biotech and mid-pharma RFPs.

TypeDirect peer
Description

Mid-to-large US-headquartered full-service CRO with strong therapeutic-area focus (oncology, rare disease); the closest pure-play comparable in size, operating model, and TA emphasis to Excelya.

TypeDirect peer
Description

Global full-service CRO with deep oncology, rare disease, and clinical technology offerings; competes with Excelya for mid-sized pharma and biotech trial awards across all phases.

TypeDirect peer
Description

Full-service clinical CRO spun out of Labcorp offering end-to-end Phase I–IV services plus FSP; directly competes in the same therapeutic and resourcing categories as Excelya.

TypeDirect peer
Description

Full-service biopharmaceutical solutions organization combining CRO services with commercial capabilities; directly competes with Excelya in clinical operations and FSP engagements.

TypeDirect peer
Description

Global full-service CRO offering Phase I–IV clinical trial services, FSP, and lab services to biopharma; directly competes with Excelya across Full Service, FSP, and resourcing engagements.

TypeDirect peer
Description

Mid-size global CRO focused on complex therapeutic areas including CNS, oncology, and rare disease; closest size-and-TA comparable to Excelya for sponsor benchmarking.

TypeBroad incumbent
Description

Broader life sciences services platform spanning early-stage CRO, discovery, and safety assessment; overlaps with Excelya in clinical and safety/pharmacovigilance services as part of a wider portfolio.

TypeBroad incumbent
Description

Largest global CRO with deep technology and data assets (including real-world evidence); competes head-to-head with Excelya on large sponsor RFPs while also defining the Tier-1 benchmark Excelya differentiates against.

TypeEmerging player
Description

European-headquartered mid-size CRO offering full-service and FSP solutions across multiple therapeutic areas; another regional peer overlapping with Excelya's geographic and service footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Excelya

Contract Research Organization Servicesexcelya.com

Excelya is a France-headquartered, global full-service Contract Research Organization delivering clinical trial services through Full Service, FSP, and Resourcing models to biotech, pharmaceutical, and medical device sponsors across 25+ countries.

What Excelya does

Excelya is a France-headquartered, global full-service Contract Research Organization (CRO) founded in 2014 that delivers clinical research services to biotech, pharmaceutical, and medical device sponsors. The company operates through three commercial engagement models (Full Service CRO, Functional Service Provider, and Clinical Resourcing) delivered across eight Centers of Excellence (Clinical Operations, Pharmacovigilance & Safety, Data Management, eTMF Management, Statistics & Programming, Medical Affairs, Regulatory Affairs, and Quality Assurance) and six therapeutic areas (Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease & Vaccines, Pain Treatment & CNS, and Late Phase & RWE). Across 25+ countries and 16 offices, Excelya employs 1,000+ professionals and reports having supported more than 550 clinical trials.

The company's technology stack is built on partnerships rather than proprietary infrastructure: eTMF runs on Veeva Vault (formalized through a 2021 Veeva Services Partner relationship), and clinical data management supports three of the top five EDC platforms including Viedoc and Oracle Clinical One. Real-world evidence work is differentiated by OMOP Common Data Model expertise, enabling harmonized vocabulary mapping (SNOMED, RxNorm) and federated analytics across hundreds of millions of patient records. Excelya generated ~€70M in combined revenues in 2020 following a same-day acquisition of three European CROs (Zeincro, The Clinical Company, Koehler eClinical), scaling the workforce from a pre-deal base to 800 employees across 24 European countries.

The business model is professional services revenue billed under multi-year contracts with quote-based pricing tied to project scope and engagement model. Go-to-market is enterprise field sales supported by direct RFP submission and active participation in industry conferences (PSI, PV Europe, OCT Europe, ACDM, UBIQ). Customer evidence is anchored by a 10-year pharmacovigilance partnership with UCB and case studies spanning top-20 global pharma, biopharma, generics, and CAR-T developers. In November 2025, Eurazeo acquired a minority stake via a sponsorless leveraged buyout earmarked for growth, US expansion, AI/automation investment, and a co-founder-led management transition.

Excelya firmographics

Firmographics
Name
Excelya
Legal name
EXCELYA GROUP
Website
https://excelya.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Excelya is a France-headquartered, global full-service Contract Research Organization delivering clinical trial services through Full Service, FSP, and Resourcing models to biotech, pharmaceutical, and medical device sponsors across 25+ countries.
Ownership category
akta.pro rank

Excelya industry classification

Industry
Product category
Contract Research Organization Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Clinical research services
  • Contract research organization
  • Pharmacovigilance services
  • Clinical data management
  • Biostatistics programming

Where Excelya is headquartered

Location

Headquarters

HQ city
Boulogne-billancourt
HQ country
France
HQ region
Europe

Offices11 records

Markets served

Excelya business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Research Services: Excelya generates revenue through providing comprehensive clinical research organization services including full-service CRO, Functional Service Provider (FSP) arrangements, and clinical resourcing solutions to biotech, pharma, and medical device companies.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractFull Service CRO Model
OtherMulti-year contractFunctional Service Provider (FSP)
OtherMulti-year contractClinical Resourcing

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Excelya product offering

Product offering

Core offering

Excelya is a global full-service Contract Research Organization (CRO) that delivers clinical research services to biotech, pharmaceutical, and medical device organizations through three contractable engagement models: Full Service CRO (end-to-end trial management), Functional Service Provider (FSP), and Clinical Resourcing. The offering spans eight Centers of Excellence—Clinical Operations, Pharmacovigilance & Safety, Clinical Data Management, Statistics & Programming, Medical Affairs & Medical Writing, eTMF Management, Regulatory Affairs, and Quality Assurance—delivered across six therapeutic specializations including Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease, Pain Treatment & CNS, and Late Phase & Real-World Evidence.

Product overview

Excelya is a global full-service Contract Research Organization (CRO) offering clinical research services through three engagement models: Full Service CRO (end-to-end trial management), Functional Service Provider (FSP), and Clinical Resourcing. The company operates through eight Centers of Excellence (Clinical Operations, Pharmacovigilance & Safety, Clinical Data Management, Statistics & Programming, Medical Affairs & Medical Writing, eTMF Management, Regulatory Affairs, and Quality Assurance) and covers six therapeutic areas (Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease, Pain Treatment & CNS, and Late Phase & RWE). Excelya delivers services across 25+ countries with 1000+ experts and 16 offices, supporting Biotech, Pharma, and Medical Device organizations from early-phase through post-marketing studies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Full Service CRO
  • Functional Service Provider (FSP)
  • Clinical Resourcing
  • Clinical Operations
  • Pharmacovigilance & Safety
  • Clinical Data Management
  • Statistics & Programming
  • Medical Affairs & Medical Writing
  • eTMF Management
  • Regulatory Affairs
  • Quality Assurance

Quantifiable outcome

  • 16% cost reduction achieved for clients
  • +4 more outcomes

Companies that use Excelya

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Excelya technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature4 records

Excelya partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and flagship.

  • Veeva SystemscoreTechnology or Integration · 1 September 2021Partnership with Veeva Systems as primary eTMF provider, enabling Excelya to offer best-in-class electronic Trial Master File management services to clients using market-leading software combined with professional expertise.
  • ZeincrocoreStrategic or Co-development Partner · 6 July 2020Zeincro, a CRO primarily operating in Central-Eastern & Southern Europe with expertise in clinical operations, safety and medical affairs, joined Excelya Group. The acquisition expanded Excelya's European footprint to 24 countries.
  • The Clinical CompanycoreStrategic or Co-development Partner · 6 July 2020The Clinical Company, a full-service CRO present in Belgian and Dutch markets specializing in clinical operations, joined Excelya Group to expand services in Benelux region.
  • Koehler eClinicalcoreStrategic or Co-development Partner · 6 July 2020Koehler eClinical, a German specialty CRO with focus on biostatistics and data solutions including proprietary software VITESSA, joined Excelya Group to strengthen data-centric capabilities.
  • UCBflagshipStrategic or Co-development Partner · 1 January 201510-year pharmacovigilance partnership between Excelya and UCB, evolved from operational service delivery to a mature 'one team' model. Excelya provides 24 PV professionals supporting UCB locally across Europe with monthly operational meetings and proactive communication.

Scale indicators14 records

Recent moves8 records

Expansion highlights6 records

Excelya competitors and assessment

Company assessment

Emerging players

  • KCR: European-based CRO with overlapping therapeutic areas (oncology, rare disease) and similar mid-size positioning; competes with Excelya for European biotech and mid-pharma RFPs.
  • TFS HealthScience: European-headquartered mid-size CRO offering full-service and FSP solutions across multiple therapeutic areas; another regional peer overlapping with Excelya's geographic and service footprint.

Direct peers

  • Medpace: Mid-to-large US-headquartered full-service CRO with strong therapeutic-area focus (oncology, rare disease); the closest pure-play comparable in size, operating model, and TA emphasis to Excelya.
  • Parexel: Global full-service CRO with deep oncology, rare disease, and clinical technology offerings; competes with Excelya for mid-sized pharma and biotech trial awards across all phases.
  • Fortrea (formerly Labcorp Drug Development): Full-service clinical CRO spun out of Labcorp offering end-to-end Phase I–IV services plus FSP; directly competes in the same therapeutic and resourcing categories as Excelya.
  • Syneos Health: Full-service biopharmaceutical solutions organization combining CRO services with commercial capabilities; directly competes with Excelya in clinical operations and FSP engagements.
  • ICON plc: Global full-service CRO offering Phase I–IV clinical trial services, FSP, and lab services to biopharma; directly competes with Excelya across Full Service, FSP, and resourcing engagements.
  • Worldwide Clinical Trials: Mid-size global CRO focused on complex therapeutic areas including CNS, oncology, and rare disease; closest size-and-TA comparable to Excelya for sponsor benchmarking.

Broad incumbents

  • Charles River Laboratories: Broader life sciences services platform spanning early-stage CRO, discovery, and safety assessment; overlaps with Excelya in clinical and safety/pharmacovigilance services as part of a wider portfolio.
  • IQVIA: Largest global CRO with deep technology and data assets (including real-world evidence); competes head-to-head with Excelya on large sponsor RFPs while also defining the Tier-1 benchmark Excelya differentiates against.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Excelya social profiles

Digital presence

Excelya compliance and trust

Trust signal

Compliance5 records

Excelya financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Excelya leadership team

Management profile

Number of profiles

Profiles13 records

Excelya subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Excelya funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Excelya M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Excelya

What does Excelya do?

Excelya is a global full-service Contract Research Organization (CRO) that delivers clinical research services to biotech, pharmaceutical, and medical device organizations through three contractable engagement models: Full Service CRO (end-to-end trial management), Functional Service Provider (FSP), and Clinical Resourcing. The offering spans eight Centers of Excellence—Clinical Operations, Pharmacovigilance & Safety, Clinical Data Management, Statistics & Programming, Medical Affairs & Medical Writing, eTMF Management, Regulatory Affairs, and Quality Assurance—delivered across six therapeutic specializations including Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease, Pain Treatment & CNS, and Late Phase & Real-World Evidence.

Is Excelya a public or private company?

Excelya is a private company. It is classified as private equity controlled and is currently operating.

When was Excelya founded?

Excelya was founded in 2014. It employs 501 to 1,000 people.

Where is Excelya based?

Excelya is headquartered in Boulogne-billancourt, France, in the Europe region.

How does Excelya make money?

One revenue line is on record: clinical Research Services.

Who are Excelya's main competitors?

Emerging players on record are KCR and TFS HealthScience. Direct peers are Medpace, Parexel, Fortrea (formerly Labcorp Drug Development), Syneos Health, ICON plc and Worldwide Clinical Trials. Broad incumbents are Charles River Laboratories and IQVIA.

Does Excelya have an API?

No public API is recorded for Excelya.

What industry is Excelya in?

Excelya's product category is Contract Research Organization Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 54171 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioXconomyEurazeo Invests in French CRO Excelya for GrowthFrench private equity firm Eurazeo has invested in clinical research organization Excelya to support its expansion through targeted external growth. The financing is supplemented by bank debt from Banque Populaire Val de France, Banque Populaire Rives de Paris, BNP Paribas, Crédit Lyonnais, and Société Générale. This investment coincides with co-founder Frédéric Paqueville stepping back from operations as Excelya aims to become the preferred partner for mid-sized European drug companies.InvestorsinhealthcareFrance: Eurazeo invests in Excelya to support CRO’s external growth ambitionsFrance-based investor Eurazeo is joining Excelya, a European contract research organization (CRO), as a lead investor alongside the company's management team. This investment is intended to support Excelya's development and external growth ambitions. The article indicates that full details of the transaction are behind a subscription paywall.EurazeoEURAZEO SUPPORTS EXCELYA IN A NEW PHASE OF DEVELOPMENTEurazeo has joined Excelya, a European clinical research services provider, as a lead investor alongside its management team to support the Group's continued development and external growth ambitions. The transaction includes a management transition as Frédéric Paqueville steps back from operational leadership, with key managers working alongside CEO François Moisson. Excelya, founded in 2014 and having contributed to over 550 clinical studies, aims to become the European leader in clinical research while investing in AI and automation solutions.ExcelyaEURAZEO supports EXCELYA in a New phase of DevelopmentEurazeo has joined Excelya as a lead investor alongside its management team to support the clinical research services provider's development and external growth ambitions. The investment, managed by Eurazeo's Flex Financing team, coincides with a management transition as Frédéric Paqueville steps back from his operational role to be succeeded by key managers working with CEO François Moisson. Excelya aims to leverage this partnership to accelerate its European expansion and position itself as the preferred partner for mid-sized European pharmaceutical companies, ultimately aspiring to become the European leader in clinical research.PR NewswireExcelya fait progresser la gestion des données cliniques avec Veeva Vault EDCExcelya, a global independent contract research organization, has selected Veeva Vault EDC as its electronic data capture platform for clinical trials, replacing its prior systems with a solution that offers faster database build cycles and zero downtime during mid-study design modifications. The adoption also includes Veeva RTSM for randomization and trial supply management, integrated with Vault EDC to streamline data workflows and accelerate drug development timelines. Veeva Systems, the US-based cloud software provider, announced the partnership on 10 November 2022 in Barcelona.PR NewswireExcelya avanza en la gestión de datos clínicos con Veeva Vault EDCVeeva Systems announced on November 9, 2022, that Excelya, a global contract research organization (CRO), is implementing Veeva Vault EDC for electronic data capture, data cleaning, and reporting in clinical trials. The partnership gives Excelya faster database build cycles and zero downtime for mid-study design modifications, enhancing its ability to accelerate high-quality trial design and execution. Excelya is also leveraging Veeva RTSM for randomization and trial supply management, integrated with Vault EDC to streamline data workflows.PR NewswireExcelya treibt die Verwaltung klinischer Daten mit Veeva Vault EDC voranVeeva Systems announced that Excelya, a global contract research organization, has adopted Veeva Vault EDC for electronic data capture, data cleaning, and reporting in clinical studies. The implementation provides Excelya with faster database creation cycles and eliminates downtime when making design changes mid-study. Excelya also uses Veeva RTSM for randomization and trial supply management to further optimize data workflows.PR NewswireExcelya Advances Clinical Data Management with Veeva Vault EDCExcelya, a global CRO, announced it is using Veeva Vault EDC for electronic data capture, cleaning, and reporting in clinical trials. The adoption aims to accelerate study builds and enable faster mid-study amendments with zero downtime. Excelya also integrates Veeva RTSM for randomization and trial supply management.PR NewswireMedical Affairs Outsourcing Market, 2027The global Medical Affairs Outsourcing Market is projected to grow from US$1,415.00 million in 2019 to US$3,287.12 million by 2027, at a compound annual growth rate (CAGR) of 11.2% during the forecast period 2020-2027. Market growth is driven by the increasing number of clinical trials worldwide, rising adoption of outsourcing activities, and growing R&D expenditures, while rising costs of drug development and clinical trials act as restraints. Key market players including ICON PLC, IQVIA Inc, Syneos Health, WuXi AppTec, SGS SA, PPD Inc, Parexel International Corporation, Indegene, Excelya, and UDG Healthcare plc are adopting organic and inorganic growth strategies to expand their global footprints.